SiteCentric Logo

The Platform

Site Success

About

SiteCentric Logo

The Platform

Site Success

About

SiteCentric Logo

Sep 11, 2025

SiteCentric Introduces AI Study Builder

From Protocol to Study Build in 2 Minutes

portrait of Brian Hunter
Brian Hunter

COO


At SiteCentric, our mission has always been to remove barriers that slow down clinical research. This week, we are proud to introduce a new capability that does just that: the AI Study Builder.

Traditionally, building a study into a CTMS system from a protocol can take anywhere from two to three hours, depending on the number of visits and the specific procedures performed at each visit. The process is tedious, requiring manual effort, careful interpretation, and repetitive steps. With the introduction of our AI-driven approach, this same process can now be completed in just two minutes.

The AI Builder tool ingests the trial protocol and uses the schedule of events to produce a study structure in the SiteCentric platform, ready for review and refinement. This means that what used to be a time-consuming, manual task is now automated and standardized—helping sites save time, reduce errors, and help ready for the SIV.

Key benefits include:

  • Significant time savings in study start-up activities

  • Standardized protocol interpretation for greater consistency

  • Reduced administrative burden for site staff

  • Faster movement from planning to operational execution

This innovation represents an industry first. More importantly, it reinforces SiteCentric’s commitment to developing technology that is practical, impactful, and always centered around the needs of clinical research sites.

The introduction of the AI Study Builder is a step forward not just for SiteCentric, but for the industry as a whole. By combining automation, compliance, and user-friendly design, we are helping sites focus more of their energy where it matters most—supporting patients and advancing science.

Sep 11, 2025

SiteCentric Introduces AI Study Builder

From Protocol to Study Build in 2 Minutes

portrait of Brian Hunter
Brian Hunter

COO


At SiteCentric, our mission has always been to remove barriers that slow down clinical research. This week, we are proud to introduce a new capability that does just that: the AI Study Builder.

Traditionally, building a study into a CTMS system from a protocol can take anywhere from two to three hours, depending on the number of visits and the specific procedures performed at each visit. The process is tedious, requiring manual effort, careful interpretation, and repetitive steps. With the introduction of our AI-driven approach, this same process can now be completed in just two minutes.

The AI Builder tool ingests the trial protocol and uses the schedule of events to produce a study structure in the SiteCentric platform, ready for review and refinement. This means that what used to be a time-consuming, manual task is now automated and standardized—helping sites save time, reduce errors, and help ready for the SIV.

Key benefits include:

  • Significant time savings in study start-up activities

  • Standardized protocol interpretation for greater consistency

  • Reduced administrative burden for site staff

  • Faster movement from planning to operational execution

This innovation represents an industry first. More importantly, it reinforces SiteCentric’s commitment to developing technology that is practical, impactful, and always centered around the needs of clinical research sites.

The introduction of the AI Study Builder is a step forward not just for SiteCentric, but for the industry as a whole. By combining automation, compliance, and user-friendly design, we are helping sites focus more of their energy where it matters most—supporting patients and advancing science.

Sep 11, 2025

SiteCentric Introduces AI Study Builder

From Protocol to Study Build in 2 Minutes

portrait of Brian Hunter
Brian Hunter

COO


At SiteCentric, our mission has always been to remove barriers that slow down clinical research. This week, we are proud to introduce a new capability that does just that: the AI Study Builder.

Traditionally, building a study into a CTMS system from a protocol can take anywhere from two to three hours, depending on the number of visits and the specific procedures performed at each visit. The process is tedious, requiring manual effort, careful interpretation, and repetitive steps. With the introduction of our AI-driven approach, this same process can now be completed in just two minutes.

The AI Builder tool ingests the trial protocol and uses the schedule of events to produce a study structure in the SiteCentric platform, ready for review and refinement. This means that what used to be a time-consuming, manual task is now automated and standardized—helping sites save time, reduce errors, and help ready for the SIV.

Key benefits include:

  • Significant time savings in study start-up activities

  • Standardized protocol interpretation for greater consistency

  • Reduced administrative burden for site staff

  • Faster movement from planning to operational execution

This innovation represents an industry first. More importantly, it reinforces SiteCentric’s commitment to developing technology that is practical, impactful, and always centered around the needs of clinical research sites.

The introduction of the AI Study Builder is a step forward not just for SiteCentric, but for the industry as a whole. By combining automation, compliance, and user-friendly design, we are helping sites focus more of their energy where it matters most—supporting patients and advancing science.

Browse Our Resources

Celebrating CNS Healthcare’s 2025 SCRS Standout Award

Oct 8, 2025

Redefining Clinical Trial Operations Through Site-Focused Innovation

Celebrating CNS Healthcare’s 2025 SCRS Standout Award

Oct 8, 2025

Redefining Clinical Trial Operations Through Site-Focused Innovation

Celebrating CNS Healthcare’s 2025 SCRS Standout Award

Oct 8, 2025

Redefining Clinical Trial Operations Through Site-Focused Innovation

SiteCentric Announces Another Industry First: AI Protocol Feasibility Review

Sep 23, 2025

Accelerating Protocol Review with Automated Summaries

SiteCentric Announces Another Industry First: AI Protocol Feasibility Review

Sep 23, 2025

Accelerating Protocol Review with Automated Summaries

SiteCentric Announces Another Industry First: AI Protocol Feasibility Review

Sep 23, 2025

Accelerating Protocol Review with Automated Summaries

SCRS Trailblazer Award

Jun 5, 2025

CNS Healthcare/Site Centric wins the Site Trailblazer Award at SCRS West!

SCRS Trailblazer Award

Jun 5, 2025

CNS Healthcare/Site Centric wins the Site Trailblazer Award at SCRS West!

SCRS Trailblazer Award

Jun 5, 2025

CNS Healthcare/Site Centric wins the Site Trailblazer Award at SCRS West!

See the SiteCentric Platform Up Close

Schedule a quick discovery call to get your questions answered and see a personalized demo based on what you’re looking for.

All Rights Reserved © 2025 SiteCentric.

SiteCentric, SiteCentric CTMS, and SiteCentric Clinical Trial Management Software and affiliated logos are registered trademarks owned by Clinical Neuroscience Solutions, Inc. d/b/a SiteCentric.

All other trademarks, names, and logos referenced on the SiteCentric website are the property of their respective owners. Any use of third-party trademarks is for identification and informational purposes only and does not imply any affiliation, endorsement, or sponsorship by those third parties.

All Rights Reserved © 2025 SiteCentric.

SiteCentric, SiteCentric CTMS, and SiteCentric Clinical Trial Management Software and affiliated logos are registered trademarks owned by Clinical Neuroscience Solutions, Inc. d/b/a SiteCentric.

All other trademarks, names, and logos referenced on the SiteCentric website are the property of their respective owners. Any use of third-party trademarks is for identification and informational purposes only and does not imply any affiliation, endorsement, or sponsorship by those third parties.

All Rights Reserved © 2025 SiteCentric.

SiteCentric, SiteCentric CTMS, and SiteCentric Clinical Trial Management Software and affiliated logos are registered trademarks owned by Clinical Neuroscience Solutions, Inc. d/b/a SiteCentric.

All other trademarks, names, and logos referenced on the SiteCentric website are the property of their respective owners. Any use of third-party trademarks is for identification and informational purposes only and does not imply any affiliation, endorsement, or sponsorship by those third parties.